19:23 Fri 26 May 2017
Advanced Oncotherapy - Conversion of Convertible Loan Notes
("
Conversion of Convertible Loan Notes
Number of CLN converted: 25 |
Total nominal value of the CLN converted: |
Lowest VWAP in 15 days preceding conversion notice: £0.2135 Conversion price: |
Number of shares issued from the conversion: 1,000,000 |
Shares issued for the satisfaction of the conversion fees: 30,000 |
Application will be made for admission to trading on AIM ("Admission") of the 1,030,000 new Ordinary Shares deriving from the conversion of the CLN and in satisfaction of the conversion fees and it is expected that Admission will occur on or around
Additional fees of c.
Total voting rights
Following Admission, the Company's enlarged issued share capital will comprise 79,287,194 Ordinary Shares, with voting rights. The Company does not hold any Ordinary Shares in treasury. Therefore the total number of Ordinary Shares in the Company with voting rights will be 79,287,194. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the
|
|
Dr. |
Tel: +44 20 3617 8728 |
|
|
|
|
Stockdale Securities (Nomad & Joint Broker) |
|
|
Tel: +44 20 7601 6100 |
|
|
|
|
|
Tel: +44 20 7710 7600 |
|
|
Walbrook PR (Financial PR & IR) |
Tel: +44 20 7933 8780 or avo@walbrookpr.com |
|
Mob: +44 7980 541 893 / Mob: +44 7876 741 001 |
About
This information is provided by RNS
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE